Management of COVID-19-related immune thrombocytopenia by rhTPO
Blood Res
.
2021 Sep 30;56(3):205-207.
doi: 10.5045/br.2021.2020049.
Authors
Xuzhao Zhang
1
2
,
Min Li
2
3
,
Tao Chen
2
3
,
Dong Lv
2
4
,
Pengfei Xia
2
5
,
Wenbin Qian
1
Affiliations
1
Department of Hematology, Hangzhou, China.
2
Aid Hubei Medical Team, Hangzhou, China.
3
Neurology Intensive Care Unit, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
4
Department of Respiratory Medicine, Shangyu People's Hospital, Shangyu, China.
5
Department of Respiratory Medicine, Lanxi People's Hospital, Lanxi, China.
PMID:
34462401
PMCID:
PMC8478614
DOI:
10.5045/br.2021.2020049
No abstract available
Publication types
Letter